Research Progress on Histone Deacetylases Regulating Programmed Cell Death in Atherosclerosis

Area of Science:

• Epigenetics
• Molecular Biology
• Cardiovascular Disease Research

Background:

• Histone deacetylases (HDACs) are epigenetic enzymes influencing gene transcription and chromatin structure.
• HDACs play a significant role in the pathophysiology of atherosclerosis.
• Programmed cell death, including apoptosis, autophagy, and programmed necrosis, is implicated in atherosclerosis progression.

Purpose of the Study:

• To provide an overview of HDACs and programmed cell death mechanisms.
• To elaborate on the specific roles of HDACs in regulating apoptosis, autophagy, and programmed necrosis in atherosclerosis.
• To offer a theoretical basis for novel therapeutic strategies against atherosclerosis.

Main Methods:

• Review of existing literature on HDACs, programmed cell death, and atherosclerosis.
• Analysis of the molecular mechanisms by which HDACs modulate apoptosis, autophagy, and programmed necrosis.
• Synthesis of current evidence to highlight the therapeutic potential of targeting HDACs.

Main Results:

• HDACs are key regulators of multiple programmed cell death pathways relevant to atherosclerosis.
• Specific HDACs influence apoptosis, autophagy, and programmed necrosis in the context of atherosclerotic disease.
• Targeting HDACs presents a promising avenue for managing atherosclerosis.

Conclusions:

• HDACs are critical mediators in the programmed cell death processes underlying atherosclerosis.
• Further research into HDAC-mediated cell death mechanisms can inform the development of targeted therapies.
• Modulating HDAC activity holds potential for preventing and treating atherosclerosis.